Company & Sponsor Intelligence
University Hospital, Limoges
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed1
Countries1
Therapeutic footprint
autismepilepsyother_psychiatry
Indexed studies
NCT02947880Evaluation of the Efficiency of Treatment by BUMETANIDE on Autistic Children With a Known Ethiology
autism · FrancePHASE2
autism · FrancePHASE2
NCT01979432The Cognitive and Cardiovascular Health in the Elderly Study
other_psychiatry · FranceNA
other_psychiatry · FranceNA
NCT01374204Epilepsy-Associated Stigma
epilepsy · FranceCOMPLETED
epilepsy · FranceCOMPLETED
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →